Cargando…
Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
FK317 is a member of a new class of bioreductive agents that exhibit strong cytotoxicity against various human cancer cells. The effect of FK317 was found to be stronger than that of mitomycin C (MMC), adriamycin (ADR) or cisplatin (CDDP). Alkaline elution analysis indicated that FK317 formed inters...
Autores principales: | Naoe, Yoshinori, Inami, Masamichi, Kawamura, Ikuo, Nishigaki, Fusako, Tsujimoto, Susumu, Matsumoto, Sanae, Manda, Toshitaka, Shimomura, Kyoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921879/ https://www.ncbi.nlm.nih.gov/pubmed/9703365 http://dx.doi.org/10.1111/j.1349-7006.1998.tb03269.x |
Ejemplares similares
-
Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro
por: Naoe, Yoshinori, et al.
Publicado: (1998) -
FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice
por: Naoe, Yoshinori, et al.
Publicado: (1998) -
Anti‐cachectic Effect of FK317, a Novel Anti‐cancer Agent, in Colon26 and LX‐1 Models in Mice
por: Naoe, Yoshinori, et al.
Publicado: (1998) -
Binding Sites of Droloxifene in the Cytosol of 7,12‐Dimethylbenz[α]anthracene‐induced Rat Mammary Tumor Cells
por: Kawamura, Ikuo, et al.
Publicado: (1994) -
Bioreductive drugs and the selective induction of tumour hypoxia.
por: Bremner, J. C., et al.
Publicado: (1990)